Arkolith/Insider Trading/HRTX/Form 4

Johnson Craig A

DirectorHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Dec 23, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2021Grant(A)10K—$013K
Dec 21, 2021Sell(S)250$9.73$2K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2021Grant(A)21K—$021K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-071169) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML